Previous 10 | Next 10 |
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal Touchon, President and Chief E...
2023-07-17 07:29:07 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The world of biotech stocks is notoriously difficult to predict. History is littered with companies that appeared destined for superstar status only to crash and burn. A brutal FDA approv...
2023-07-13 17:25:28 ET Gainers: ACADIA Pharmaceuticals ( ACAD ) +29% . Intuitive Machines ( LUNR ) +25% . Atara Biotherapeutics ( ATRA ) +5% . Xilio Therapeutics ( XLO ) +5% . Alector ( ALEC ) +3% . Losers: Theseus ...
2023-06-08 10:04:22 ET Gainers: Aclarion ( ACON ) +35% . Bone Biologics ( BBLG ) +17% . Atara Biotherapeutics ( ATRA ) +16% . Medigus ( MDGS ) +15% . AVITA Medical ( RCEL ) +13% . Losers: Panbela Therapeutics ( PBLA ) ...
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal Touchon, President and Chief E...
Real-World Results Demonstrate Objective Response Rate (ORR) of 67% in 24 EBV+ PTLD Patients 91% Overall Survival (OS) at One Year for Patients Responding to Tab-cel Compared to 34% for Non-Responders Tab-cel Safety Profile Consistent with Phase 3 ALLELE Study Findings ...
2023-05-18 17:35:14 ET Gainers: Brightcove ( BCOV ) +6% . GSI Technology ( GSIT ) +5% . Clarus ( CLAR ) +4% . Pyxis Oncology ( PYXS ) +4% . Atara Biotherapeutics ( ATRA ) +2% . Losers: CrowdStrike Holdings ( ...
2023-05-18 18:38:14 ET Gainers: Farfetch Limited ( FTCH ) +18% . Ouster ( OUST ) +9%. Guardforce AI ( GFAI ) +4% . GSI Technology ( GSIT ) +4%. Losers: CaliberCos ( CWD ) -9%. Flowers Foods ( FLO ) -5%. DXC Te...
2023-05-14 23:25:14 ET Summary Seth Klarman’s 13F portfolio value decreased from $6.13B to $5.85B this quarter. Baupost Group increased Alphabet and Fidelity National Information Services while dropping Meta Platforms, Micron Technology, and Amazon.com. The portfolio co...
2023-05-12 17:45:30 ET Gainers: GSI Technology ( GSIT ) +16% . Telos ( TLS ) +8% . Arcturus Therapeutics Holdings ( ARCT ) +5% . Atara Biotherapeutics ( ATRA ) +4% . Health Catalyst ( HCAT ) +4% . Losers: Zapp Electric Ve...
News, Short Squeeze, Breakout and More Instantly...
Atara Biotherapeutics Inc. Company Name:
ATRA Stock Symbol:
NASDAQ Market:
Atara Biotherapeutics Inc. Website:
Prescription Drug User Fee Act (PDUFA) Target Action Date of January 15, 2025 If Approved, Tab-cel Would Be First Approved Therapy in U.S. for EBV+ PTLD BLA Acceptance Triggers $20 Million Milestone Payment from Pierre Fabre Laboratories, with Additional $60 Million Milestone if A...
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal Touchon, President and Chief E...
2024-06-27 22:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...